Zimmer Biomet (ZBH) FY Conference June 09, 2025 09:20 AM ET Speaker0 Okay. Good morning, everyone. We'll go ahead and get started here. Very pleased to welcome Ivan Tornos, Chairman and CEO of Zimmer Biomet and Sukhi Upade, Executive Vice President and CFO. As with all of these sessions, if you have a question, feel free to raise your hand. I certainly have have plenty to keep us to keep us going here, but obviously, we wanna keep this as interactive as possible. So why don't we start with with a topic that ...

It has been about a month since the last earnings report for Zimmer Biomet (ZBH) . Shares have lost about 0.5% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Zimmer due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turn ...

Zimmer Biomet’s (ZBH) strategic priorities, new product launches and focus on international expansion bolster our confidence in this stock. Yet, the difficult macroeconomic situation and FX issues are concerning. The stock carries a Zacks Rank #3 (Hold).Favorable Factors for ZBHDespite challenging market conditions in the form of pricing pressure, the last few quarters witnessed gradual stability in the global musculoskeletal market with better-than-expected sales growth in certain geographies, banking on i ...

Zimmer Biomet Holdings, Inc ZBH reported better-than-expected earnings for the first quarter on Monday.The company posted first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77. The orthopedic giant reported sales of $1.91 billion, up 1.1% on a reported basis (+2.3% on constant currency), almost in line with the consensus of $1.9 billion.“We are proud of our team’s continued execution and performance to start the year, as we delivered solid first quarter resul ...

Zimmer Biomet's (NYSE: ZBH ) stock dropped close to 10% after the company reported soft first quarter results and meaningfully reduce full year earnings guidance. While there are a range of factors impacting Zimmer Biomet's business at the moment, weakness is beingRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be achieved ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2025 Commission File Number 001-16407 ZIMMER BIOMET HOLDINGS, INC. (Exact name of registrant as specified in its charter) 345 East Main Street, Warsaw, IN 46580 (Address of principal executive offices) Telephone: (574) 373-3333 Securities registered pursuant to Section 12(b) of the Act: | Title of ea ...

Zimmer Biomet Holdings, Inc. (ZBH) posted first-quarter 2025 adjusted earnings per share (EPS) of $1.81, which beat the Zacks Consensus Estimate by 2.3%. The adjusted figure, however, declined 6.7% year over year.The quarter’s adjustments included certain amortization, restructuring and other cost reduction initiatives, inventory and manufacturing-related charges and European Union Medical Device Regulation-related charges, among others.On a reported basis, the company registered earnings of 91 cents per sh ...

Zimmer Biomet (ZBH) reported $1.91 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.1%. EPS of $1.81 for the same period compares to $1.94 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.89 billion, representing a surprise of +0.88%. The company delivered an EPS surprise of +2.84%, with the consensus EPS estimate being $1.76.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stre ...

Zimmer Biomet (ZBH) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $1.94 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.84%. A quarter ago, it was expected that this orthopedic device maker would post earnings of $2.30 per share when it actually produced earnings of $2.31, delivering a surprise of 0.43%.Over the last four quarters, t ...

Zimmer Biomet (ZBH) Q1 2025 Earnings Call May 05, 2025 08:30 AM ET Company Participants David DeMartino - Senior VP of Investor RelationsIvan Tornos - President & CEOSuketu Upadhyay - Executive VP & CFODavid Roman - Managing DirectorTravis Steed - Managing Director - Equity ResearchChris Pasquale - Partner - Medical Devices & SuppliesMatt Taylor - Managing DirectorJoshua Jennings - Managing DirectorJoanne Wuensch. - Managing DirectorCaitlin Cronin - DirectorRichard Newitter - Managing Director Conference Ca ...